1
|
M HockelP VaupelTumor hypoxia: definitions
and current clinical, biologic, and molecular aspectsJ Natl Cancer
Inst93266276200110.1093/jnci/93.4.26611181773
|
2
|
P VaupelA MayerHypoxia in cancer:
significance and impact on clinical outcomeCancer Metastasis
Rev26225239200710.1007/s10555-007-9055-117440684
|
3
|
A WoutersB PauwelsF LardonJB
VermorkenReview: implications of in vitro research on the effect of
radiotherapy and chemotherapy under hypoxic
conditionsOncologist12690712200710.1634/theoncologist.12-6-69017602059
|
4
|
M HockelK SchlengerB AralM MitzeU
SchafferP VaupelAssociation between tumor hypoxia and malignant
progression in advanced cancer of the uterine cervixCancer
Res564509451519968813149
|
5
|
M NordsmarkSM BentzenV RudatPrognostic
value of tumor oxygenation in 397 head and neck tumors after
primary radiation therapy. An international multi-center
studyRadiother
Oncol771824200510.1016/j.radonc.2005.06.03816098619
|
6
|
M NordsmarkJ AlsnerJ KellerHypoxia in
human soft tissue sarcomas: adverse impact on survival and no
association with p53 mutationsBr J
Cancer8410701075200110.1054/bjoc.2001.172811308256
|
7
|
GL SemenzaTargeting HIF-1 for cancer
therapyNat Rev Cancer3721732200310.1038/nrc1187
|
8
|
GL SemenzaEvaluation of HIF-1 inhibitors
as anticancer agentsDrug Discov
Today12853859200710.1016/j.drudis.2007.08.00617933687
|
9
|
PH MaxwellMS WiesenerGW ChangThe tumour
suppressor protein VHL targets hypoxia-inducible factors for
oxygen-dependent
proteolysisNature399271275199910.1038/2045910353251
|
10
|
H ZhongAM De MarzoE LaughnerOverexpression
of hypoxia-inducible factor 1alpha in common human cancers and
their metastasesCancer Res5958305835199910582706
|
11
|
HK HauglandV VukovicM PintilieExpression
of hypoxia-inducible factor-1alpha in cervical carcinomas:
correlation with tumor oxygenationInt J Radiat Oncol Biol
Phys53854861200210.1016/S0360-3016(02)02815-812095550
|
12
|
GJ HutchisonHR ValentineJA
LoncasterHypoxia-inducible factor 1alpha expression as an intrinsic
marker of hypoxia: correlation with tumor oxygen, pimonidazole
measurements, and outcome in locally advanced carcinoma of the
cervixClin Cancer
Res1084058412200410.1158/1078-0432.CCR-03-0135
|
13
|
P BirnerB GatterbauerG OberhuberExpression
of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its
impact on prognosis and on
neoangiogenesisCancer92165171200110.1002/1097-0142(20010701)92:1%3C165::AID-CNCR1305%3E3.0.CO;2-F11443623
|
14
|
M SchindlSF SchoppmannH
SamoniggOverexpression of hypoxia-inducible factor 1alpha is
associated with an unfavorable prognosis in lymph node-positive
breast cancerClin Cancer Res818311837200212060624
|
15
|
P BirnerM SchindlA ObermairC PlankG
BreiteneckerG OberhuberOverexpression of hypoxia-inducible factor
1alpha is a marker for an unfavorable prognosis in early-stage
invasive cervical cancerCancer Res6046934696200010987269
|
16
|
DL GillespieK WhangBT RagelJR FlynnDA
KellyRL JensenSilencing of hypoxia inducible factor-1alpha by RNA
interference attenuates human glioma cell growth in vivoClin Cancer
Res1324412448200710.1158/1078-0432.CCR-06-269217438103
|
17
|
X ZhangT KonH WangEnhancement of
hypoxia-induced tumor cell death in vitro and radiation therapy in
vivo by use of small interfering RNA targeted to hypoxia-inducible
factor-1alphaCancer
Res6481398142200410.1158/0008-5472.CAN-03-230115548675
|
18
|
L ChenP FengS LiEffect of
hypoxia-inducible factor-1alpha silencing on the sensitivity of
human brain glioma cells to doxorubicin and etoposideNeurochem
Res34984990200910.1007/s11064-008-9864-918937067
|
19
|
X SongX LiuW ChiHypoxia-induced resistance
to cisplatin and doxorubicin in non-small cell lung cancer is
inhibited by silencing of HIF-1alpha geneCancer Chemother
Pharmacol58776784200610.1007/s00280-006-0224-716532342
|
20
|
J KesslerA HahnelH WichmannHIF-1alpha
inhibition by siRNA or chetomin in human malignant glioma cells:
effects on hypoxic radioresistance and monitoring via CA9
expressionBMC Cancer10605201010.1186/1471-2407-10-60521050481
|
21
|
T SakaiT SameshimaM MatsufujiN KawamuraK
DobashiY MizuiPladienolides, new substances from culture of
Streptomyces platensis Mer-11107. I Taxonomy, fermentation,
isolation and screeningJ Antibiot (Tokyo)571731792004
|
22
|
A RapisardaB UranchimegDA
ScudieroIdentification of small molecule inhibitors of
hypoxia-inducible factor 1 transcriptional activation pathwayCancer
Res6243164324200212154035
|
23
|
LA HuxhamAH KyleJH BakerLK NykilchukAI
MinchintonMicroregional effects of gemcitabine in HCT-116
xenograftsCancer
Res6465376541200410.1158/0008-5472.CAN-04-098615374965
|
24
|
H OkuyamaH EndoT AkashikaK KatoM
InoueDownregulation of c-MYC protein levels contributes to cancer
cell survival under dual deficiency of oxygen and glucoseCancer
Res701021310223201010.1158/0008-5472.CAN-10-272020980433
|
25
|
D VordermarkA KatzerK BaierP KraftM
FlentjeCell type-specific association of hypoxia-inducible factor-1
alpha (HIF-1 alpha) protein accumulation and radiobiologic tumor
hypoxiaInt J Radiat Oncol Biol
Phys5812421250200410.1016/j.ijrobp.2003.11.03015001269
|
26
|
RK BruickSL McKnightA conserved family of
prolyl- 4-hydroxylases that modify
HIFScience29413371340200110.1126/science.106637311598268
|
27
|
P JaakkolaDR MoleYM TianTargeting of
HIF-alpha to the von Hippel-Lindau ubiquitylation complex by
O2-regulated prolyl
hydroxylationScience292468472200110.1126/science.105979611292861
|
28
|
DE SwinsonJL JonesD RichardsonCarbonic
anhydrase IX expression, a novel surrogate marker of tumor hypoxia,
is associated with a poor prognosis in non-small-cell lung cancerJ
Clin Oncol21473482200310.1200/JCO.2003.11.13212560438
|
29
|
B BlouwH SongT TihanThe hypoxic response
of tumors is dependent on their microenvironmentCancer
Cell4133146200310.1016/S1535-6108(03)00194-612957288
|
30
|
L LiX LinM StaverEvaluating
hypoxia-inducible factor-1 alpha as a cancer therapeutic target via
inducible RNA interference in vivoCancer
Res6572497258200510.1158/0008-5472.CAN-04-442616103076
|
31
|
J ChenS ZhaoK NakadaDominant-negative
hypoxia-inducible factor-1 alpha reduces tumorigenicity of
pancreatic cancer cells through the suppression of glucose
metabolismAm J
Pathol16212831291200310.1016/S0002-9440(10)63924-712651620
|
32
|
N ChanIM PiresZ BencokovaContextual
synthetic lethality of cancer cell kill based on the tumor
microenvironmentCancer
Res7080458054201010.1158/0008-5472.CAN-10-235220924112
|